Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinical stringency greatly improves mutation detection in Rett syndrome.

Julie Gauthier1, Giovana de Amorim, Gevork N Mnatzakanian

  • 1Department of Biology, McGill University, Montreal, Canada.

The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|October 18, 2005
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neuropsychological functioning and progression in Lafora disease.

Epilepsia·2026
Same author

FRRS1L gene replacement ameliorates disease phenotypes in the mouse model of developmental and epileptic encephalopathy 37.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026
Same author

Characterization of the genotypic and phenotypic spectrum of TCF7L2-related neurodevelopmental disorder (TRND).

Genetics in medicine : official journal of the American College of Medical Genetics·2026
Same author

Correction: Variants in NR6A1 as a cause for congenital renal, vertebral and uterine anomalies.

Human genetics·2026
Same author

Lafora disease gene therapy: EPM2A but not EPM2B overexpression results in Lafora body formation.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026
Same author

Variants in NR6A1 as a cause for congenital renal, vertebral and uterine anomalies.

Human genetics·2026

Diagnosing Rett syndrome (RTT) using Revised Diagnostic Criteria (RDC) significantly increases the detection rate of MECP2 gene mutations. Adhering to RDC improves diagnostic accuracy for this severe neurodevelopmental disorder in girls.

Area of Science:

  • Genetics
  • Neuroscience
  • Pediatrics

Background:

  • Rett syndrome (RTT) is a severe neurodevelopmental disorder affecting girls, primarily caused by mutations in the MECP2 gene.
  • Established in the 1980s, RTT is a common cause of mental retardation in females, with evolving diagnostic criteria.
  • Revised Diagnostic Criteria (RDC) have been developed to refine RTT diagnosis.

Purpose of the Study:

  • To investigate the impact of using RDC on MECP2 mutation detection rates in Canadian RTT patients.
  • To compare mutation detection in patients diagnosed with and without strict adherence to RDC.

Main Methods:

  • Compared MECP2 mutation detection rates between two groups of Canadian patients.
  • One group (n=35) was diagnosed historically without specific criteria; the other (n=101) met strict RDC.

Related Experiment Videos

  • Mutation detection utilized dHPLC followed by sequencing of all MECP2 exons.

    • Main Results:

    • MECP2 mutation detection was significantly higher in patients diagnosed using strict adherence to RDC.
    • Detection rates were 20% for patients diagnosed without RDC and 72% for those diagnosed with RDC.

    Conclusions:

    • Clinical diagnostic procedures, specifically adherence to RDC, significantly influence MECP2 mutation detection rates in RTT.
    • The study underscores the critical role of standardized diagnostic tools in assessing neurodevelopmental disorders like RTT.